Carson Wealth (CWM LLC)
IMNM icon

Carson Wealth (CWM LLC)’s Immunome IMNM Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.81K Buy
357
+15
+4% +$334 ﹤0.01% 4874
2025
Q4 		$7K Buy
342
+61
+22% +$1.07K ﹤0.01% 4701
2025
Q3 		$3K Buy
281
+1
+0.4% +$10 ﹤0.01% 4903
2025
Q2 		$3K Buy
280
+258
+1,173% +$2.12K ﹤0.01% 4774
2025
Q1 		$0 Buy
22
+5
+29% +$48 ﹤0.01% 5122
2024
Q4 		$0 Sell
17
-5
-23% -$60 ﹤0.01% 5022
2024
Q3 		$0 Buy
22
+12
+120% +$171 ﹤0.01% 4968
2024
Q2 		$0 Buy
+10
New +$156 ﹤0.01% 4738

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Carson Wealth (CWM LLC)'s IMNM Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Immunome (IMNM) stake by 4.4% in Q1 2026, buying an estimated $334 and bringing the position to 357 shares worth $7.81K. The position accounts for ﹤0.01% of the portfolio, ranked #4874.

Carson Wealth (CWM LLC) first reported a position in IMNM in Q2 2024 and has held it in 8 quarters since. 201 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Carson Wealth (CWM LLC) held 357 shares of Immunome worth $7.81K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 15 Immunome shares in Q1 2026, an estimated $334.
  • Immunome made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4874 holding.
  • Carson Wealth (CWM LLC) first reported a position in Immunome in Q2 2024 and has held it in 8 quarters since.
  • 201 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.